Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Expert Review of Molecular Diagnostics|December 11, 2020
dPCR application in liquid biopsies: divide and conquerAndrea Moreno-Manuel, Silvia Calabuig-Fariñas, Antonia Obrador-Hevia, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancerRoy M Bremnes, Tom Dønnem, Samer Al-Saad, et al.Expert Review of Molecular Diagnostics|February 4, 2020
A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancerSusana Torres, Álvaro González, Alberto Jacobo Cunquero Tomas, et al.Oncoimmunology|February 16, 2017
Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patientsMarta Usó, Eloísa Jantus-Lewintre, Silvia Calabuig-Fariñas, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 16, 2011
Oncology outside hospital: a new experience for the benefit of longer survivorsCarlos Camps, Vega Iranzo, Cristina Caballero, et al.Lung Cancer (Amsterdam, Netherlands)|September 6, 2005
Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?Carlos Camps, Rafael Sirera, Roy Bremnes, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 22, 2010
The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancerRoy M Bremnes, Khalid Al-Shibli, Tom Donnem, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 18, 2011
The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expressionMaría José Safont, Mireia Gil, Rafael Sirera, et al.Lung Cancer (Amsterdam, Netherlands)|April 1, 2006
Analysis of c-kit expression in small cell lung cancer: prevalence and prognostic implicationsCarlos Camps, Rafael Sirera, Roy M Bremnes, et al.Lung Cancer (Amsterdam, Netherlands)|November 16, 2010
The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patientsCarlos Camps, Eloisa Jantus-Lewintre, Andrea Cabrera, et al.Pageof 7